Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company
will release results for its fourth quarter of Fiscal Year 2009 ended
April 30, 2009, prior to the market opening on Tuesday July 14, 2009 and
will hold a conference call to discuss its financial results at 10 a.m.
Eastern Time.
To access the conference call, dial toll free 866-383-8003, or
617-597-5330 for international callers, five minutes before the
conference. The passcode of the conference call is 49044098.
A replay of the conference call will be available after 12 p.m. on July
14, 2009, for one week by calling toll free 888-286-8010, or
617-801-6888 for international callers. The passcode for the replay is
27915077.
Hi-Tech is a specialty pharmaceutical company developing, manufacturing
and marketing generic and branded products. The Company specializes in
difficult to manufacture liquid and semi-solid dosage forms and produces
a range of sterile ophthalmic, otic and inhalation products. The
Company's Health Care Products Division is a leading developer and
marketer of branded prescription and OTC products for the diabetes
marketplace. Hi-Tech’s ECR Pharmaceuticals division markets branded
prescription products.
Forward-looking statements (statements which are not historical facts)
in this Press Release are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are not promises or guarantees and investors are cautioned
that all forward-looking statements involve risks and uncertainties,
including but not limited to the impact of competitive products and
pricing, product demand and market acceptance, new product development,
the regulatory environment, including without limitation, reliance on
key strategic alliances, availability of raw materials, fluctuations in
operating results and other results and other risks detailed from time
to time in the Company's filings with the Securities and Exchange
Commission. These statements are based on management's current
expectations and are naturally subject to uncertainty and changes in
circumstances. We caution you not to place undue reliance upon any such
forward looking statements which speak only as of the date made. Hi-Tech
is under no obligation to, and expressly disclaims any such obligation
to, update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
Hi-Tech Pharmacal Co., Inc.
Bill Peters, CFO, 631-789-8228
